___

• Lin, W.W., Karin, M. (2007). A cytokine-mediated link between innate immunity, inflammation, and cancer. Journal of Clinical Investigation, 117(5), 1175-1183.
• Ciaramella, V., Della Corte, C.M., Ciardiello, F., Morgillo, F. (2018). Kisspeptin and Cancer: Molecular interaction, Biological Functions, and Future Perspectives. Frontiers in Endocrinology, 9(115), 1-5. 3.
• Sun, Y., Wang, R., Qiao, M., Xu, Y., Guan, W., Wang, L. (2018). Cancer associated fibroblasts tailored tumor microenvironment of therapy resistance in gastrointestinal cancers. J Cell Physiol. doi: 10.1002/jcp.26433. [Epub ahead of print]
• Hassanzade, J., Molavi E. Vardanjani, H., Farahmand, M., Rajaiifard, A.R. (2011). Incidence and Mortality Rate of Common Gastrointestinal Cancers in South of Iran, a Population Based Study. Iranian Journal of Cancer Prevention, 4(4):163-169.
• Beutner, U., Lorenz, U., Illert, B., Rott, L., Timmermann, W., Vollmers, H.P., Müller-Hermelink, H.K., Thiede, A., Ulrichs, K. (2008). Neoadjuvant therapy of gastric cancer with the human monoclonal IgM antibody SC-1: impact on the immune system. Oncology Reports, 19(3), 761-769.
• Elinav, E., Nowarski, R., Thaiss, C.A., Hu, B., Jin, C., Flavell, R.A. (2013). Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms. Nature Reviews Cancer, 13(11), 759-771.
• Shah, N.M., Herasimtschuk, A.A., Boasso, A., Benlahrech, A., Fuchs, D., Imami, N., Johnson, M.R. (2017). Changes in T Cell and Dendritic Cell Phenotype from Mid to Late Pregnancy Are Indicative of a Shift from Immune Tolerance to Immune Activation”. Frontiers in Immunology, 8(1138), 1-14.
• Inancli, S.S., Caner, S., Balkan, F., Tam, A.A., Guler, G., Ersoy R., Cakir, B. (2014). Urinary neopterin levels in patients with thyroid cancer. Indian Journal of Otolaryngology and Head & Neck Surgery, 66(3), 302-328.
• Akgul, E.O., Aydın, İ., Caycı, T., Kurt, Y.G., Aydın, F.N., Agıllı, M. (2013). The Indicator of Cellular Immun Response in Body Fluids: Neopterin. Gülhane Tıp Dergisi, 55, 1-7.
• Chuang, S.C., Boeing, H., Vollset, S.E., Midttun, Q., Ueland, P.M., Bueno-de-Mesquita, B., Lajous, M., Fagherazzi, G., Boutron-Ruault, M.C., Kaaks, R., Küehn, T., Pischon, T., Drogan, D., Tjønneland, A., Overvad, K., Quirós, J.R., Agudo, A., Molina-Montes, E., Dorronsoro, M., Huerta, J.M., Barricarte, A., Khaw, K.T., Wareham, N.J., Travis, R.C., Trichopoulou, A., Lagiou, P., Trichopoulos, D., Masala, G., Agnoli, C., Tumino, R., Mattiello, A., Peeters, P.H., Weiderpass, E., Palmqvist, R., Ljuslinder, I., Gunter, M., Lu, Y., Cross, A.J., Riboli, E., Vineis, P., Aleksandrova, K. (2016). Cellular immune activity biomarker neopterin is associated hyperlipidemia: results from a large population-based study. Immun Ageing, 13(5), 1-11.
• Zuo, H., Tell, G.S., Vollset, S.E., Ueland, P.M., Nygård, O., Midttun, Q., Meyer, K., Ulvik, A., Eussen, S.J. (2014). Interferon-γ-induced inflammatory markers and the risk of cancer: the Hordaland Health Study. Cancer, 120(21), 3370-3377.
• Volgger, B.M., Windbichler, G.H., Zeimet, A.G., Graf, A.H., Bogner, G., Angleitner-Boubenizek, L., Rohde, M., Denison, U., Sliutz, G., Fuith, L.C., Fuchs, D., Marth, C. (2016). Long-term significance of urinary neopterin in ovarian cancer: a study by the Austrian Association for Gynecologic Oncology (AGO). Annals of Oncology, 27(9), 1740-1746.
• Engin, A.B., Karahalil, B., Karakaya, A.E., Engin, A. (2015). Helicobacter pylori and serum kynurenine-tryptophan ratio in patients with colorectal cancer. World Journal of Gastroenterology, 21(12), 3636-3643.
• Sucher, R., Schroecksnadel, K., Weiss, G., Margreiter, R., Fuchs, D., Brandacher, G. (2010). Neopterin, a prognostic marker in human malignancies. Cancer Letters, 287(1), 13-22.
• Krcmova, L., Solichova, D., Melichar, B., Kasparova, M., Plisek, J., Sobotka, L., Solich, P. (2011). Determination of neopterin, kynurenine, tryptophan and creatinine in human serum by high throuput HPLC. Talanta, 85(3), 1466-1471.
• Hacışevki, A., Baba, B., Sezer, S., Özkan, Y. (2013). Increased kynurenine/tryptophan and neopterin levels in hemodialysis. Oxidation Communications, 36(1), 246-253.
• Yanchun, L., Zhidong, H. (2011). Significance of humoral neopterin in clinical diagnostics and prognosis. Journal of Medical Colleges of PLA, 26, 45-51.
• Chen, G., Zhang, F.J., Gong, M., Yan, M. (2007). Effect of perioperative autologous versus allogeneic blood transfusion on the immune system in gastric cancer patients. Journal of Zhejiang University SCIENCE B, 8(8), 560-565.
• Armstrong, H., Bording-Jorgensen, M., Dijk, S., Wine, E. (2018). The complex interplay between chronic inflammation, the microbiome, and cancer: Understanding disease progression and what we can do to prevent it. Cancers, 10(3), 1-29.
• Qu, X., Tang, Y., Hua, S. (2018). Immunological approaches towards cancer and inflammation: A cross talk. Frontiers in Immunology, 9(563), 1-19.
• Grivennikov, S.I., Greten, F.R., Karin, M. (2010). Immunity, inflammation, and cancer. Cell, 140(6), 883-899.
• Landskron, G., De la Fuente, M., Thuwajit, P., Thuwajit, C., Hermoso, M.A. (2014). Chronic inflammation and cytokines in the tumor microenvironment. Journal of Immunology Research, 2014(149185), 1-19.
• Yan, M., Chen, G., Fang, L.L., Liu, Z.M., Zhang, X.L. (2005). Immunologic changes to autologous transfusion after operational trauma in malignant tumor patients: neopterin and interleukin-2. Journal of Zhejiang University SCIENCE B, 6(1), 49-52.
• Melichar, B., Spisarová, M., Bartoušková, M., Krčmová, L.K., Javorská, L., Študentová, H. (2017). Neopterin as a biomarker of immune response in cancer patients. Annals of Translational Medicine, 5(13), 1-12.
• El-Akawi, Z.J., Abu-Awad, A.M., Sharara, A.M., Khader, Y. (2010). The importance of alpha-1 antitrypsin (alpha1-AT) and neopterin serum levels in the evaluation of non-small cell lung and prostate cancer patients. Neuro Enocrinology Letters, 31(1), 113-116.
• Isci Bostanci, E., Ugras Dikmen, A., Girgin, G., Gungor, T., Baydar, T., Nuri Danisman, A. (2017). A new diagnostic and prognostic marker in endometrial cancer: Neopterin. International Journal of Gynecological Cancer, 27(4), 754–758.
• Melicharová, K., Kalábová, H., Krcmová, L., Urbánek, L., Solichová, D., Melichar, B. (2010). Effect of comorbidity on urinary neopterin in patients with breast carcinoma. European Journal of Cancer Care, 19(3), 340-345.
• Girgin, G., Tolga Sahin, T., Fuchs, D., Kasuya, H., Yuksel, O., Tekin, E., Baydar, T. (2009). Immune system modulation in patients with malignant and benign breast disorders: tryptophan degradation and serum neopterin. The International Journal of Biological Markers, 24(4), 265-270.
• Kalábová, H., Krcmová, L., Kasparová, M., Plísek, J., Laco, J., Hyspler, R., Klozová, H., Solichová, D., Melichar, B. (2011). Prognostic significance of increased urinary neopterin concentrations in patients with breast carcinoma. European journal of gynaecological oncology, 32(5), 525-529.
• Thein, M.S., Kohli, A., Ram, R., Ingaramo, M.C., Jain, A., Fedarko, N.S. (2017). Chitotriosidase, a marker of innate immunity, is elevated in patients with primary breast cancer. Cancer Biomark, 19(4), 383-391.
• Babic, A., Schnure, N., Neupane, N.P., Zaman, M.M., Rifai, N., Welch, M.W., Brais, L.K., Rubinson, D.A., Morales-Oyarvide, V., Yuan, C., Zhang, S., Poole, E.M., Wolpin, B.M., Kulke, M.H., Barbie, D.A., Wong, K., Fuchs, C.S., Ng, K. (2018). Plasma inflammatory cytokines and survival of pancreatic cancer patients. Clinical and Translational Gastroenterology, 9(4), 145: 1-12.
• Talar-Wojnarowska, R., Gasiorowska, A., Olakowski, M., Lekstan, A., Lampe, P., Malecka-Panas, E. (2010). Clinical value of serum neopterin, tissue polypeptide-specific antigen and CA19-9 levels in differential diagnosis between pancreatic cancer and chronic pancreatitis. Pancreatology, 10(6), 689-694.
• Huang, J.Y., Butler, L.M., Midttun, Ø., Ulvik, A., Wang, R., Jin, A., Gao, Y.T., Ueland, P.M., Koh, W.P., Yuan, J.M. (2018). A prospective evaluation of serum kynurenine metabolites and risk of pancreatic cancer. PLoS One, 13(5), e0196465.
• Melichar, B., Solichová, D., Svobodová, I., Urbánek, L., Veselý, P., Melicharová, K. (2006). Urinary neopterin in patients with liver tumors. Tumori, 92(4), 318-322.
• Aleksandrova, K., Chuang, S.C., Boeing, H., Zuo, H., Tell, G.S., Pischon, T., Jenab, M., Bueno-de-Mesquita, B., Vollset, S.E., Midttun, Ø., Ueland, P.M., Fedirko, V., Johansson, M., Weiderpass, E., Severi, G., Racine, A., Boutron-Ruault, M.C., Kaaks, R., Kühn, T., Tjønneland, A., Overvad, K., Quirós, J.R., Jakszyn, P., Sánchez, M.J., Dorronsoro, M., Chirlaque, M.D., Ardanaz, E., Khaw, K.T., Wareham, N.J., Travis, R.C., Trichopoulou, A., Lagiou, P., Trichopoulos, D., Palli, D., Sieri, S., Tumino, R., Panico, S., May, A.M., Palmqvist, R., Ljuslinder, I., Kong, S.Y., Freisling, H., Gunter, M.J., Lu, Y., Cross, A.J., Riboli, E., Vineis, P. (2015). A prospective study of the immune system activation biomarker neopterin and colorectal cancer risk. Journal of the National Cancer Institute. 107(4), 1-18.
• Melichar, B., Solichová, D., Melicharová, K., Malírová, E., Cermanová, M., Zadák, Z. (2006). Urinary neopterin in patients with advanced colorectal carcinoma. The International Journal of Biological Markers, 21(3), 190–198.
• Hronek, M., Zadak, Z., Solichova, D., Jandik, P., Melichar, B. (2000). The association between specific nutritional antioxidants and manifestation of colorectal cancer. Nutrition, 16(3), 189-191.
• Unal, B., Kocer, B., Altun, B., Surmeli, S., Aksaray, S., Balci, M., Ozlu, B., Cengiz, O. (2009). Serum neopterin as a prognostic indicator in patients with gastric carcinoma. Journal of Investigative Surgery, 22(6), 419–425.
• Engin, A.B., Engin, A., Sepici-Dincel, A. (2010). Influence of surgical trauma on neopterin concentrations in gastric carcinoma patients. Tumori, 96(4), 589-593.
• Hacışevki, A., Baba, B., Gönenç, A., Aslan, S. (2012). Protein carbonyl content as the most general and well-used biomarker of severe oxidative stress. Oxidation Communications, 35(2), 413-422.
• Gupta, D., Lis, C.G. (2010). Pretreatment serum albumin as a predictor of cancer survival: a systematic review of the epidemiological literature. Nutrition Journal. 9(69), 1-41.
• Du, X.J., Tang, L.L., Mao, Y.P., Sun, Y., Zeng, M.S., Kang, T.B., Jia, W.H., Lin, A.H., Ma, J. (2014). The pretreatment albumin to globulin ratio has predictive value for long-term mortality in nasopharyngeal carcinoma. Plos One. 9(4), e94473, 1-8.
• Hrnciarikova, D., Hyspler, R., Vyroubal, P., Klemera, P., Hronek, M., Zadak, Z. (2009). Serum lipids and neopterin in urine as new biomarkers of malnutrition and inflammation in the elderly. Nutrition, 25(3), 303-308.
• Battelli, M. G., Polito, L., Bortolotti, M., Bolognesi, A. (2016). Xanthine oxidoreductase in cancer: more than a differentiation marker. Cancer Medicine, 5(3), 546-557.
• Fini, M.A., Elias, A., Johnson, R.J., Wright, R.M. (2012). Contribution of uric acid to cancer risk, recurrence, and mortality. Clinical and Translational Medicine, 1(1), 16.